Get help now — free helplines

You can call any of these for free. You do not need a diagnosis, an appointment, or a crisis to call — questions and plain exhaustion are reasons enough.

  • Alzheimer's Association 24/7 Helpline 800-272-3900 24 hours a day, 365 days a year Free, confidential support and information for people with dementia, caregivers, families and the public. Master's-level clinicians. Also Spanish.
  • 988 Suicide & Crisis Lifeline 988 24/7 Call or text 988, or chat at 988lifeline.org. For anyone in emotional distress or a mental-health crisis, including caregivers.
  • Alzheimer's Foundation of America (AFA) Helpline 866-232-8484 9:00 am - 9:00 pm ET, seven days a week Licensed social workers providing support, info and referrals. Also text message and web chat. Text: 646-586-5283

In a medical emergency, call 911. More numbers, and what each line does, on the help page.

Newest in this topic

  1. Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies 2023-07-26
  2. Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework 2023-07-12
  3. Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints 2023-06-29

Studies

4 studies carry this tag.

Date range

2022 to 2023

Top journals

  • CNS neuroscience & therapeutics 1
  • Molecular psychiatry 1
  • Nature communications 1
  • Translational neurodegeneration 1

Newest first, then by address. Each study has a usefulness score out of 100 (rubric version 4.0); tap a score to see what makes it up. Tags were assigned automatically from each study's title and summary. The same studies as a filter in the library.

  1. Individual regional associations between Aβ-, tau- and neurodegeneration (ATN) with microglial activation in patients with primary and secondary tauopathies

    ✓ Peer-reviewed alzhub usefulness score 57 out of 100. Molecular psychiatry 2023-07-26 TREM2 and immune genetics

    β-amyloid (Aβ) and tau aggregation as well as neuronal injury and atrophy (ATN) are the major hallmarks of Alzheimer's disease (AD), and biomarkers for these hallmarks have been linked to neuroinflammation.

  2. Alzheimer's disease diagnostic accuracy by fluid and neuroimaging ATN framework

    ✓ Peer-reviewed alzhub usefulness score 71 out of 100. CNS neuroscience & therapeutics 2023-07-12 Biomarkers

    Our findings suggest that plasma, CSF, and neuroimaging biomarkers differ considerably within the ATN framework; the most accurate target biomarkers for diagnosing AD were the CSF-A, neuroimaging-T, and neuroimaging-N within each ATN modality.

  3. Head-to-head comparison of plasma and PET imaging ATN markers in subjects with cognitive complaints

    ✓ Peer-reviewed alzhub usefulness score 55 out of 100. Translational neurodegeneration 2023-06-29 Biomarkers

    Plasma p-tau181, as well as 18 F-florbetapir and 18 F-Florzolotau PET imaging can be considered as interchangeable biomarkers in the assessment of Aβ status in symptomatic stages of AD. 18 F-Florzolotau and 18 F-FDG PET imaging could serve as biomarkers for the severity of cognitive impairment.

  4. Dissociation of tau pathology and neuronal hypometabolism within the ATN framework of Alzheimer's disease

    ✓ Peer-reviewed alzhub usefulness score 47 out of 100. Nature communications 2022-03-21 Brain scans and imaging

    Alzheimer's disease (AD) is defined by amyloid (A) and tau (T) pathologies, with T better correlated to neurodegeneration (N).

All topic tags with their study counts